Minnesota-based Medtronic to get $17M for artificial pancreas research

Fridley-based Medtronic will be getting $17 million over the next three years for an initiative aimed at stabilizing blood sugar levels in diabetics. The medical technology company announced Friday that they are getting the money from the Juvenile Diabetes Research Foundation and the Helmsley Charitable Trust to improve existing and develop new artificial pancreas technology.
Author:
Updated:
Original:

Fridley-based Medtronic will be getting $17 million over the next three years for an initiative aimed at stabilizing blood sugar levels in diabetics. The medical technology company announced Friday that they are getting the money from the Juvenile Diabetes Research Foundation and the Helmsley Charitable Trust to improve existing and develop new artificial pancreas technology.

Next Up

police tape, crime scene

Man and woman, aged 55 and 62, found dead in their home

The St. Louis County Sheriff's Office is investigating.

Gov. Tim Walz

Walz: COVID-19 guidance for Christmas likely to be similar to Thanksgiving

Thanksgiving featured a ban on social gatherings with non-household members.

CCI 3

Mall of America is offering a virtual Santa experience this year

People can virtually tour Santa's Candy Cane Institute.

PD Shimmers 4

Annual guide to finding holiday lights displays in MN is released

More than 80 holiday displays are on this year's list.

duluth police department

Duluth police officer charged in September shooting

The officer, who is a five-year veteran, is charged with two felonies.

Screen Shot 2020-11-30 at 1.31.42 PM

Enbridge gets final approval to start construction on Line 3 replacement

The project has attracted criticism from environmental and tribal groups.

Kirk Cousins

Is it a 4-team race for the final NFC playoff spot?

The key for Minnesota likely requires winning on the road against two top NFC teams.

coronavirus

Nov. 30 COVID-19 update: Hospitalizations reach new high mark

There are fewer than 100 staffed ICU beds available in Minnesota.

Related

Medtronic to study device that could lead to artificial pancreas for diabetics

Medtronic has a green light from regulators to begin studies that could lead to automated insulin delivery. A feature in the company's insulin pumps stops sending insulin when blood sugar levels get too low.

Is Medtronic going after India's largest med-tech company?

A respected Indian business publication is reporting that Medtronic is negotiating with an Indian medical technology company to make a strategic investment in it. Trivitron Healthcare is reportedly India’s largest med tech company. The Fridley-based company has not commented specifically on the deal, however, CEO Omar Ishrak has made no secrets about his interest in India.

CEO: Medtronic's focus paying off

After a solid last year and last quarter, Medtronic Inc. CEO Omar Ishrak is reiterating that his company's commitment is to growth through globalization, innovation and enhancing value, not just creating new medical technology products. It's what Ishrak has consistently preached in the year-plus since he took the helm at the world's largest medical device company.

Medtronic cutting 1,000 jobs despite growing profits

The Fridley-based medical device maker plans to eliminate positions in facilities around the globe, including 220 positions at its Mounds View-based division. Medtronic topped expectations in the fourth quarter, but continues to struggle with the sale of heart rhythm devices as well as devices used in spine surgery.

Medtronic workers in India mentor Minn. high school students

It's not unusual for Minnesota-company professionals mentoring high school students. So it was this past spring with Fridley-based Medtronic Inc. and students at Buffalo High School. But there was a twist. The Medtronic employees mentoring Brenda Diekman's accounting class weren't local. They are halfway around the world – in Mumbai, India.

Medical alert issued for Medtronic's Entrust defibrillators

British regulators warn the device has a battery defect that can fail to properly shock a heart back into a normal rhythm. Patients are encouraged to see their cardiologists to ensure an audible "low-battery" alert is working properly. Fridley-based Medtronic denied any wrong doing, but settled lawsuits regarding battery issues in its Marquis line of defibrillators less than four years ago.

Feds close probe into Medtronic's marketing of its Infuse bone graft product

The U.S. Department of Justice spent four years looking into whether the Fridley-based manufacturer encouraged doctors to use the product in ways not described on the FDA-approved label. Medtronic denies any wrongdoing, but still faces civil lawsuits and agreed to pay $85 million in March to settle a federal securities lawsuit.